The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Agensys; Kite/Gilead
Stock and Other Ownership Interests - Allogene Therapeutics; Amgen; Gilead Sciences; Vertex
 
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Gilead Sciences
Retreatment (reTx) of patients (pts) with refractory large B-cell lymphoma with axicabtagene ciloleucel (axi-cel) in ZUMA-1.
 
Frederick Lundry Locke
Stock and Other Ownership Interests - Cellular Biomedicine Group
Consulting or Advisory Role - Alimera Sciences; Calibr; Celgene; Cellular Biomedicine Group; EcoR1 Capital; GammaDelta Therapeutics; Gerson Lehrman Group; Novartis; WUGEN, Inc.
Research Funding - Kite, a Gilead company (Inst)
Patents, Royalties, Other Intellectual Property - CAR T Cells with Enhanced Metabolic Fitness. Serial Number: 62/939,727 (Inst); Double Mutant Survivin Vaccine. US010414810B2. (Inst); Evolutionary Dynamics of Non-Hodgkin Lymphoma CAR-T cell therapy. Serial Number: 62/879,534. (Inst); Methods of Enhancing CAR T Cell Therapies. Serial Number: 62/892,292. (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company
 
Nancy L. Bartlett
Consulting or Advisory Role - Seagen
Research Funding - ADC Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Genentech (Inst); Immune Design (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Seagen (Inst)
 
Caron A. Jacobson
Honoraria - Celgene; Humanigen; Kite/Gilead; Nkarta; Novartis; Pfizer; Precision Biosciences
Consulting or Advisory Role - Celgene; Humanigen; Kite/Gilead; Nkarta; Novartis; Pfizer; Precision Biosciences
Speakers' Bureau - Axis Pharma; Clinical Care Options
Research Funding - Pfizer
Travel, Accommodations, Expenses - Celgene; Humanigen; Kite/Gilead; Novartis; Pfizer; Precision Biosciences
 
Olalekan O. Oluwole
Consulting or Advisory Role - Bayer; Kite/Gilead; Pfizer; Spectrum Pharmaceuticals
 
Javier Munoz
Honoraria - Kyowa Hakko Kirin; Seagen
Consulting or Advisory Role - Alexion Pharmaceuticals; Bayer; BeiGene; Bristol-Myers Squibb; Celgene; Fosun Kite; Genentech; Gilead Sciences; Innovent Biologics; Janssen; Juno Therapeutics; Kite, a Gilead company; Kyowa Hakko Kirin; Pfizer; Pharmacyclics; Seagen
Speakers' Bureau - Abbvie/Genentech; Acrotech Biopharma; AstraZeneca; Bayer; BeiGene; BeiGene; Celgene; Gilead Sciences; Kite, a Gilead company; Kyowa Hakko Kirin; Pharmacyclics/Janssen; Seagen; Verastem
Research Funding - Celgene; Genentech/Abbvie; Incyte; Kite, a Gilead company; Millennium; Pharmacyclics/Janssen; Portola Pharmaceuticals; Seagen
 
Lazaros J. Lekakis
Consulting or Advisory Role - Incyte; Janssen; Jazz Pharmaceuticals
 
Max S. Topp
Consulting or Advisory Role - Amgen; Kite/Gilead; Kite/Gilead; Novartis; Regeneron; Roche
Research Funding - Boehringer Ingelheim (Inst); Kite, a Gilead company (Inst); Regeneron (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Celgene; Regeneron
 
Irit Avivi
No Relationships to Disclose
 
Jenny J. Kim
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
 
Rong Chu
No Relationships to Disclose
 
Lianqing Zheng
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
 
John M. Rossi
No Relationships to Disclose
 
Adrian Bot
Employment - Gilead Sciences; Kite, a Gilead company
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences
 
Sattva Swarup Neelapu
Honoraria - Aptitude Health; Bio Ascend; Medscape; MJH Life Sciences
Consulting or Advisory Role - Alimera Sciences; Celgene; Cell Medica; Gilead Sciences; Incyte; Kite, a Gilead company; Legend Biotech; Merck Sharp & Dohme; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics
Research Funding - Acerta Pharma; Alimera Sciences; Bristol-Myers Squibb; Cellectis; Gilead Sciences; Karus Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; poseida therapeutics; Precision Biosciences; Unum Therapeutics
Patents, Royalties, Other Intellectual Property - Patents related to cellular therapy
Travel, Accommodations, Expenses - Alimera Sciences; Celgene; Chugai Pharma; Kite/Gilead; Legend Biotech; Medscape; Merck; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics